Another Extendicare Class Action Lawsuit Filed over Nursing Home Neglect in Wisconsin

Nursing home operator Extendicare faces a third class action suit, this time filed on behalf of all residents of their nursing homes in Wisconsin. Similar Extendicare class action lawsuits have been filed in Washington and Minnesota, with all of the cases alleging that the company places profits over patient care by admitting residents that they are not properly equipped to handle.

The Wisconsin Extendicare lawsuit was filed Friday in the Circuit Court for Milwaukee County by one resident, but seeks class action status on behalf of all residents who have been treated at 26 different nursing homes operated by Extendicare in the state.

Extendicare is one of the largest nursing home operators in the United States and Canada, with as many as 226 homes in North America and over 30,000 beds.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The lawsuit alleges that Extendicare fraudulently advertises services that they are not capable of performing and admits ill residents without hiring the necessary staff to provide even adequate care.

According to a July 2008 article in the Milwaukee Journal-Sentinel, 20 out of the 26 Extendicare nursing homes in Wisconsin have been cited for at least one serious violation in care over the past three years and the nursing home operator has paid over $2.3 million to settle violations that led to the 2003 death of one Wisconsin resident.

Similar Extendicare class action lawsuits were filed in August 2008 in Washington and last month in Minnesota.

All of the cases highlight Extendicare’s “24/7 Extendicare Admission Policy”, which green flags individuals with serious medical conditions for immediate admission without proper assessment of the facility’s ability to meet the patient’s needs or the needs of other residents who are already living in the nursing home. This places elderly and ill individuals at risk for serious injury caused by nursing home neglect.

Extendicare has indicated that they intend to defend all of the nursing home class action lawsuits, and they have called the allegations incorrect and misleading.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.